Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1017 participants
OBSERVATIONAL
2018-12-01
2023-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure
NCT03206593
Insulin Resistance and Severity of Coronary Artery Disease
NCT05215821
Irisin Expression and Gene Polymorphism in Type II Diabetic Patients With and Without CAD
NCT04957823
New Diabetes Mellitus and Pre-Diabetes With First-time Diagnosed Coronary Artery Disease
NCT05208424
Association Between Triglycerides Glucose Ratio With HOMA -IR as Indicators of Insulin Resistance in Obese Adults
NCT06358989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A total of 14,708 patients who had undergone coronary angiography at least once were examined. After applying exclusion criteria, 1017 eligible cases were selected for data analysis.
The following data was recorded for the included patients: demographic data, past medical history (such as DM, hypertension, etc.), systolic and diastolic blood pressure, weight and height, fasting plasma glucose (FPG), hemoglobin A1c (HbA1c), total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and serum creatinine (Cr). Body mass index (BMI) was calculated as weight (Kg) divided by the square of height (m2). Obesity was defined as BMI ≥ 30 Kg/m2.
Laboratory values were selected from the time before angiography, and if not available, from the time shortly after the angiography. This helped us find those values which could best represent the metabolic state of patients at the time of angiography, while reducing the confounding effect of statin use.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
coronary artery disease
patients with coronary angiography of at least one vessel with more than 50% stenosis
triglyceride to glucose ratio
Ratio of triglyceride level to glucose
triglycerdie to HDL ratio
Ratio of triglyceride to HDL cholesterol
no coronary artery disease
patient with no stenosis in coronary angiography
triglyceride to glucose ratio
Ratio of triglyceride level to glucose
triglycerdie to HDL ratio
Ratio of triglyceride to HDL cholesterol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
triglyceride to glucose ratio
Ratio of triglyceride level to glucose
triglycerdie to HDL ratio
Ratio of triglyceride to HDL cholesterol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* history of prior coronary angiography or revascularization (percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG))
* serum creatinine \> 1.4 mg/dL
* history of chronic kidney disease (CKD)
* cancer,
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shiraz University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Javad Kojuri
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Javad Kojuri, MD. MS.
Role: PRINCIPAL_INVESTIGATOR
Professor kojuri cardiology clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shiraz University of Medical Sciences
Shiraz, Fars, Iran
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jahangiri S, Mosalamiaghili SA, Heydarzadeh R, Yousefzadeh M, Golchin Vafa R, Zarifkar H, Assadian K, Sohrabizadeh S, Zarifkar H, Sadeghi M, Hosseini N, Montaseri M, Hosseini SA, Kojuri J. Predicting the presence and severity of coronary artery disease using surrogate markers of insulin resistance: A cross-sectional study. ARYA Atheroscler. 2025;21(1):44-53. doi: 10.48305/arya.2025.42573.2960.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IR.SUMS.MED.REC.1402.252
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.